Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex

Journal of Neurochemistry

Volumn 88, Issue 4, 2004, Pages 1003-1009

  Devoto, Paola ^a   Flore, Giovanna ^a   Pira, Luigi ^a   Longu, Giorgio ^a   Gessa, Gian Luigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Desipramine; Dihydroxyphenylacetic acid; GBR 12909; Microdialysis; Occipital cortex; Prefrontal cortex

Indexed keywords

12 ETHYLSULFONYL 5,8,8A,9,10,11,12,12A,13,13A DECAHYDRO 3 METHOXY 6H ISOQUINO[2,1 G][1,6]NAPHTHYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NORADRENALIN; SODIUM ION; UNCLASSIFIED DRUG; VANOXERINE; 5 HYDROXYINDOMETHACIN; 5-HYDROXYINDOMETHACIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE; INDOMETACIN; PIPERAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; HYPOTHESIS; MALE; MICRODIALYSIS; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; OCCIPITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; EXTRACELLULAR SPACE; METABOLISM; METHODOLOGY; NERVE CELL; SPRAGUE DAWLEY RAT; TIME;

ANIMALIA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CEREBRAL CORTEX; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; EXTRACELLULAR SPACE; HALOPERIDOL; INDOMETHACIN; MALE; MICRODIALYSIS; NEURONS; NOREPINEPHRINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; TIME FACTORS;

EID: 1042301274     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02239.x     Document Type: Article

References (37)

1. Carboni E., Tanda G. L., Frau R. and Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067-1070.
2. Darracq L., Blanc G., Glowinski J. and Tassin J.-P. (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J. Neurosci. 18, 2729-2739.
3. Descarries L., Lemay B., Doucet G. and Berger B. (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21, 807-824.
4. Devoto P., Flore G., Pani L. and Gessa G. L. (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry 6, 657-664.
5. Devoto P., Flore G., Pira L., Pani L. and Gessa G. L. (2002a) Origin of extracellular dopamine from noradrenergic neurons in the cerebral cortex. Soc. Neurosci. Abstr. Prog. N. 736.7.
6. Devoto P., Flore G., Pira L., Diana M. and Gessa G. L. (2002b) Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Psychopharmacology 160, 220-224.
7. Devoto P., Flore G., Vacca G., Pira L., Arca A., Casu M. A., Pani L. and Gessa G. L. (2003a) Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology 167, 79-84.
8. Devoto P., Flore G., Longu G., Pira L. and Gessa G. L. (2003b) Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse 50, 200-205.
9. Fadda F., Gessa G. L., Marcou M., Mosca E. and Rossetti Z. L. (1984) Evidence for dopamine autoreceptors in mesocortical dopamine neurons. Brain Res. 293, 67-72.
10. Feenstra M. G. P. (2000) Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Progr. Brain Res. 126, 133-163.
11. Garris P. A., Collins L. B., Jones S. R. and Wightman R. M. (1993) Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J. Neurochem. 61, 637-647.
12. Gessa G. L., Devoto P., Diana M., Flore G., Melis M. and Pistis M. (2000) Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology 22, 642-649.
13. Grenhoff J., Nisell M., Ferré S., Aston-Jones G. and Svensson T. H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. 93, 11-25.
14. Gresch P. J., Sved A. F., Zigmond M. J. and Finlay J. M. (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65, 111-116.
15. Hertel P., Nomikos G. G. and Svensson T. H. (1999) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur. J. Pharmacol. 371, 153-158.
16. Herve D., Blanc G., Glowinski J. and Tassin J.-P. (1982) Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain Res. 237, 510-516.
17. 2A-adrenoceptors in the mouse prefrontal cortex. Eur. J. Neurosci. 15, 1789-1794.
18. Kawahara Y., Kawahara H. and Westerink B. H. C. (1999) Comparison of the effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 360, 42-49.
19. Kawahara H., Kawahara Y. and Westerink B. H. C. (2001) The noradrenaline-dopamine interactions in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur. J. Pharmacol. 418, 177-186.
20. 2A-adrenoceptor subtype. Neuropharmacology 44, 882-892.
21. Li X.-M., Perry K. W., Wong D. T. and Bymaster F. P. (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136, 153-161.
22. Lindvall O., Björklund A. and Divac I. (1978) Organization of the catecholamine neurons projecting to the frontal cortex in the rat. Brain Res. 142, 1-24.
23. Linner L., Endersz H., Ohman D., Bengtsson F., Schallinh M. and Svensson T. H. (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J. Pharmacol. Exp. Ther. 297, 540-546.
24. Mazei M. S., Pluto C. P., Kirkbride B. and Pehek E. A. (2002) Effect of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res. 936, 58-67.
25. Michel M., Hiemke C. and Ghraf R. (1984) Preferential uptake of norepinephrine into dopaminergic terminals of a synaptosomal preparation from rat cerebral cortex. Brain Res. 301, 149-152.
26. 2c receptors: a comparison with citalopram. Eur. J. Neurosci. 12, 1079-1095.
27. Moron J. A., Brockington A., Wise R. A., Rocha B. A. and Hope B. T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389-395.
28. Murphy E. K., Sved A. F. and Finlay J. M. (2003) Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex of control or chronically stressed rats. Neuroscience 116, 1081-1087.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press Inc, San Diego, California.
30. Pozzi L., Invemizzi R., Cervo L., Vallebuona F. and Samanin R. (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63, 195-200.
31. Roberts D. C., Zis A. P. and Fibiger H. C. (1975) Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res. 93, 441-454.
32. Seguela P., Watkins K. C., Geffard M. and Descarries L. (1990) Noradrenaline axon terminals in adult rat neocortex: an immunohistochemical analysis in serial thin sections. Neuroscience 35, 249-264.
33. 2-adrenoceptors. J. Neurochem. 78, 685-693.
34. Tanda G., Bassareo V. and Di Chiara G. (1996) Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology 123, 127-130.
35. Westerink B. H. C., de Boer P., de Vries J. B., Kruse C. G. and Long S. K. (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur. J. Pharmacol. 361, 27-33.
36. 2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur. J. Pharmacol. 339, 113-119.
37. Zetterstrom T., Sharp T., Collin A. K. and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.